ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2020; 11(17):5236-5244. doi:10.7150/jca.46200 This issue Cite
Review
Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs
1. Department of Gastroenterology, The First People's Hospital of Yuhang District, Hangzhou, Zhejiang Province, China.
2. Department of Otolaryngology, Cixi People's Hospital, Ningbo, Zhejiang Province, China.
3. School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, China.
4. Department of Pathophysiology, College of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang Province, China.
#These authors have contributed equally to this work.
Citation:
Mi S, Gong L, Sui Z. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. J Cancer 2020; 11(17):5236-5244. doi:10.7150/jca.46200. https://www.jcancer.org/v11p5236.htm
Other stylesAbstract
In recent years, metabolic syndrome (Mets) has been a hot topic among medical scientists. Mets has an intimate relationship with the incidence and development of various cancers. As a contributory factor of Mets, hyperuricemia actually plays an inseparable role in the formation of various metabolic disorders. Although uric acid is classically considered an antioxidant with beneficial effects, mounting evidence indicates that a high serum uric acid (SUA) level may serve as a pro-oxidant to generate inflammatory reactions and oxidative stress. In this review, we describe the unrecognized role of hyperuricemia in cancer development and summarize major mechanisms linking uric acid to carcinogenesis. Furthermore, we also discuss the potential mechanism of liver metastasis of cancer and list some types of uric acid-lowering agents, which may exert anticancer effects.
Keywords: hyperuricemia, cancer risk, metabolic syndrome, liver metastasis, uric acid-lowering agents
Citation styles
APA
Mi, S., Gong, L., Sui, Z. (2020). Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. Journal of Cancer, 11(17), 5236-5244. https://doi.org/10.7150/jca.46200.
ACS
Mi, S.; Gong, L.; Sui, Z. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. J. Cancer 2020, 11 (17), 5236-5244. DOI: 10.7150/jca.46200.
NLM
Mi S, Gong L, Sui Z. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. J Cancer 2020; 11(17):5236-5244. doi:10.7150/jca.46200. https://www.jcancer.org/v11p5236.htm
CSE
Mi S, Gong L, Sui Z. 2020. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. J Cancer. 11(17):5236-5244.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.